glpamerica.

Review · not a partner · checked August 2026

Found

$289/mo

Month to month, no prepay. Read off their site August 2026.

The $99 a month in Found's FAQ needs both insurance and a twelve-month plan paid up front. Cash, month to month, the same program is $289.

Real month to month
$289/mo
Their commitment-free rung, with nothing else folded into it.
They advertise
$99/mo
12-month plan paid up front, with insurance, $1,188 today
The catch
Advertised rate needs 12 months up front
The whole ladder, with the working, is below.
Our relationship
Not a partner
Links to Found pay us nothing.
Checked
August 2026
Read off Found's own pages on that date.

What it is

Found is the insurance-first option on this roster. It works your coverage rather than routing around it, employs board-certified clinicians it says are in network for one in three Americans, and lists a wider medication toolkit than anyone else here — compounded GLP-1s, six brand GLP-1s, metformin, topiramate, Contrave.

It also runs a Medicare bridge program, and that is the clearest thing on the site, conditions and all.

What it actually costs

ADVERTISED$99ACTUALLY$289/mo
Found advertises $99. A month costs $289 because the advertised rate is the 12-month plan paid up front, with insurance.

The gap

They advertise $99 a month. That is the 12-month plan paid up front, with insurance, $1,188 on the card today. With no commitment it is $289 a month.

Compounded semaglutide

compounded semaglutide price ladder
PlanPer monthCharged today
Monthly plan, cash pay$289$289
Monthly plan, with insurance$199$199
12-month plan paid up front, cash pay$169$2,028
12-month plan paid up front, with insurance · advertised$99$1,188

Found publishes one program price covering both compounded molecules, so this ladder and the tirzepatide one below it are the same four rungs. From https://joinfound.com/plans-and-pricing: "Found's GLP-1 Program starting at $99/mo with insurance* $169/mo with cash pay*" and, in the footnote, "*Pricing based on 12-month plans paid up-front. Monthly plans start at $199/mo for insurance and $289/mo for cash-pay. Visits for insurance plans may require copays." The two annual totals are our multiplication of Found's own per-month figures, $169 × 12 and $99 × 12, because Found publishes no totals. The insurance rungs also carry a copay Found describes as "typically around $30" a visit and does not fix.

Compounded tirzepatide

compounded tirzepatide price ladder
PlanPer monthCharged today
Monthly plan, cash pay$289$289
Monthly plan, with insurance$199$199
12-month plan paid up front, cash pay$169$2,028
12-month plan paid up front, with insurance$99$1,188

Found's offer terms name both molecules together — "Save $100/mo or more on compounded tirzepatide and semaglutide when you choose a prepaid annual plan, compared to paying monthly" — and publish no separate tirzepatide figure. The compounded tirzepatide and compounded semaglutide cards in Found's own medication list carry no price at all.

Brand semaglutide

We did not find a price for this on Found's own pages when we read them in August 2026.

Found publishes brand figures that are hedged rather than fixed, so none is tabled: "Ozempic® $1100/mo", "Wegovy® from $650/mo+", "Saxenda® Pricing varies", "Victoza® Pricing varies", and Foundayo™ with no figure at all. All of them carry the footnote "**Cost does not include the subscription fees and clinical care, which vary depending on coverage."

Brand tirzepatide

We did not find a price for this on Found's own pages when we read them in August 2026.

"Zepbound® from $650/mo+" and "Mounjaro® ~$1100/mo", both hedged and both under the same footnote excluding subscription fees and clinical care.

$289 a month, cash, no commitment. That figure is in a footnote on the pricing page and nowhere else.

What the pages lead with is $99. The home page FAQ says "compounded GLP-1s starting at $99/month (with flat pricing as your dose increases)", full stop. The pricing page repeats it as "Found's GLP-1 Program starting at $99/mo with insurance* $169/mo with cash pay*", and then the asterisk does the work: "Pricing based on 12-month plans paid up-front. Monthly plans start at $199/mo for insurance and $289/mo for cash-pay." So $99 is a twelve-month prepay for someone whose insurance Found is in network with — $1,188 today on our multiplication of their figure — and $169 is the same twelve-month prepay paying cash, $2,028 today. The month you can actually buy costs $199 with insurance or $289 without.

The banner offer is worth reading rather than clicking. "Get up to $100 off your membership plan today!" resolves to "Save $100/mo or more on compounded tirzepatide and semaglutide when you choose a prepaid annual plan, compared to paying monthly." That is not a discount; it is the gap between the annual rate and the monthly one, which on Found's own numbers is $120 a month for cash payers.

The brand prices are hedged everywhere: Ozempic $1,100 a month, Wegovy and Zepbound "from $650/mo+", Mounjaro "~$1100/mo", Saxenda and Victoza "Pricing varies", Foundayo no figure. All of them sit under a footnote that removes the rest of the bill: "Cost does not include the subscription fees and clinical care, which vary depending on coverage." Found never puts a number on that subscription fee, so neither do we — it is disclosed and unpriced, and we will not add it as zero. Meanwhile the two compounded cards in the same medication list carry no price at all, on a grid where the brands do.

The full breakdown — what is included, what is extra, and what happens at higher doses — is on the Found cost page.

Who it's wrong for

Anyone without insurance who read $99. Cash, month to month, the same program is $289.

Anyone who won't prepay a year. Both advertised figures are twelve-month plans paid up front.

Anyone pricing a brand GLP-1 here. Every brand figure excludes the subscription fee and clinical care, and Found publishes no size for either.

Anyone counting on the Medicare bridge. Found's own conditions say the $50 copay does not count toward your Part D deductible or out-of-pocket maximum, low-income subsidies do not apply, and eligibility is decided by the program rather than by Found.

The American checks

Prescriber licensed in your stateNot stated
Pharmacy namedNot named
What you getCompounded semaglutide and tirzepatide on a program price, plus brand Wegovy, Ozempic, Zepbound, Mounjaro, Foundayo™, Saxenda® and Victoza® prescribed through insurance or direct pay, and non-GLP-1 options
Overseas fulfillmentNot stated
Support hoursNot published

These are the checks this site applies to every company — how we review. Not stated means we could not find it on their site, which is a finding about the site, not about the company.

On the record

Prices read 2026-08-31 on joinfound.com. The ladder is verbatim from https://joinfound.com/plans-and-pricing: "Found's GLP-1 Program starting at $99/mo with insurance* $169/mo with cash pay* — Access to board-certified Found clinicians* — Personalized care plan with GLP-1s", footnoted "*Pricing based on 12-month plans paid up-front. Monthly plans start at $199/mo for insurance and $289/mo for cash-pay. Visits for insurance plans may require copays. Prescriptions are up to medical provider's discretion. Price varies based on medication, insurance and coverage."

The unqualified version of the same figure, from the home page FAQ at https://joinfound.com/ read the same day: "On medication, Found offers more options than any other program: compounded GLP-1s starting at $99/month (with flat pricing as your dose increases), branded GLP-1s like Wegovy and Zepbound with insurance navigation support or direct-pay options, and non-GLP-1 plan options starting at $49/month. Longer plans at 3, 6, and 12 months keep your monthly cost down." Neither the insurance requirement nor the twelve-month prepay appears in that answer.

The banner offer and its terms, both on the home page on 2026-08-31: "Get up to $100 off your membership plan today!‡" and "‡Offer Details: Save $100/mo or more on compounded tirzepatide and semaglutide when you choose a prepaid annual plan, compared to paying monthly. Save $100 off today's checkout supporting brand-name GLP-1 prescriptions (including Zepbound® vials, Wegovy® pens, and Wegovy® pills) when paying cash for your Found Membership. Save $50 off today's checkout on plans supporting brand-name GLP-1 prescriptions when Found is in-network with your insurance. Med Kit plans are excluded from all discounts. This offer is valid for a one-time redemption per account." On Found's own figures the annual-versus-monthly gap for a cash payer is $289 − $169 = $120 a month, which satisfies "$100/mo or more".

The brand figures, from the medication toolkit on both the home page and the pricing page, read the same day: "Ozempic® $1100/mo", "Wegovy® from $650/mo+", "Zepbound® from $650/mo+", "Mounjaro® ~$1100/mo", "Saxenda® Pricing varies", "Victoza® Pricing varies", and "Foundayo™" with no figure. The compounded tirzepatide and compounded semaglutide cards in the same grid carry no figure either. All are footnoted "**Cost does not include the subscription fees and clinical care, which vary depending on coverage."

On insurance and copays, from the pricing page FAQ: "Cash-pay plans: You'll pay the price listed for your selected plan – no hidden fees. With Insurance: You'll pay your plan cost plus your copay, which is typically around $30 for most Found members. Your exact copay may vary based on your insurance plan and deductible status." And from the home page: "Covered by insurance for 1 in 3 Americans with copays under $30/visit for most. Medication cost separate."

The Medicare program and its conditions, verbatim from the home page on 2026-08-31: "Get Wegovy®, Foundayo®, or Zepbound® for as little as $50/mo through Medicare. The Medicare GLP-1 Bridge Program helps eligible Part D members access brand-name GLP-1 medications for as little as $50/month." And beneath it: "For eligible Medicare Part D members with a qualifying GLP-1 prescription for weight management. This is not a guarantee of coverage. Actual eligibility is determined by the Medicare GLP-1 Bridge program's criteria. The $50 copay does not count toward your Part D deductible or out-of-pocket maximum, and low-income subsidies (LIS/Extra Help) do not apply. Found is not affiliated with or endorsed by CMS."

The annual totals above are our multiplication of Found's own per-month figures, because Found publishes none: $169 × 12 = $2,028 for the cash annual plan and $99 × 12 = $1,188 for the insurance one.

What we could not find, and where we looked: we read https://joinfound.com/ and https://joinfound.com/plans-and-pricing in full on 2026-08-31, searching both for licensed in your state, 503A, 503B, pharmacy name, overseas, international and hours. Neither states that the prescriber is licensed in the patient's own state — Found does list the states its insurance plans are accepted in, which is a coverage statement rather than a licensure one — neither names a pharmacy, neither addresses fulfillment outside the United States, and neither publishes support hours. Those four rows read Not stated. The footer reads "©2025 Found Health, Inc. - All rights reserved." on a page read in 2026.

What Found sells, priced across the market

The same molecules at every other company we have reviewed, with the range each one falls in.

Words used above: Compounded, 503A, 503B, Prepay, Membership, Overseas fulfillment. All of them are in the glossary.

Check current price »

Not a partner. This link goes to Found and pays us nothing. Who pays us.

Every company we have reviewed is on the reviews index, and the reviews are written by Kevin Turner. Your privacy choices and the terms of use apply to this page.